TrialThe Journal of infectious diseases2019

Immunogenicity and Safety of 3 Formulations of a Respiratory Syncytial Virus Candidate Vaccine in Nonpregnant Women: A Phase 2, Randomized Trial.

Tino F Schwarz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.